71 results
Page 2 of 4
425
kh9rfpm
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.1
k8mj5pz dmpihdvkh
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-10.1
1ojezz7v2yi
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
bsn6fntnzn6tpo 7yi6w
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
8-K
EX-99.1
fqj9u
17 May 21
Regulation FD Disclosure
5:03pm
8-K/A
EX-99.1
kbhl4i
3 Feb 21
Other Events
4:59pm
8-K
EX-10.2
4kgcpj
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
424B3
ev8itt qy
12 Nov 20
Prospectus supplement
6:08am